π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Study to Compare the Efficacy and Safety Between Levocetirizine and Loratad...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00525382
Treatments Being Tested
To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00525278
Treatments Being Tested
Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment o...
Status
Completed
Location
Multiple Locations
Start Date
2003-09
Trial ID
NCT00524836
Treatments Being Tested
To compare the clinical efficacy of levocetirizine 5 mg and montelukast 10 ...
Status
Completed
Location
Multiple Locations
Start Date
2006-07-29
Trial ID
NCT00295022
Treatments Being Tested
This study aims to compare the effectiveness and safety of two commonly use...
Status
Completed
Location
combined military hospital ,Okara
Start Date
2025-08-18
Trial ID
NCT07365683
Treatments Being Tested
To demonstrate the non-inferiority of the efficacy of a single antihistamin...
Status
Completed
Location
Hospital Louis MOURIER
Start Date
2019-09-21
Trial ID
NCT03545464
Treatments Being Tested
The study objective is to investigate the efficacy of levocetirizine in red...
Status
Completed
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00653224
Treatments Being Tested
Comparison of clinical efficacy and safety of levocetirizine in PER continu...
Status
Completed
Location
Multiple Locations
Start Date
2005-03-01
Trial ID
NCT00160680
Treatments Being Tested
Phase IV, human pharmacology, exploratory, randomized, 3-way (3 treatment p...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00150761
Treatments Being Tested
This study will be an open-label, randomized 2-way cross-over study to eval...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-05-18
Trial ID
NCT03555890
Treatments Being Tested